Please use this identifier to cite or link to this item:
Title: Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study
Authors: Wägner, Ana María 
Sánchez-Quesada, Jose Luis
Benítez, Sonia
Bancells, Cristina
Ordóñez-Llanos, Jordi
Pérez, Antonio
UNESCO Clasification: 320502 Endocrinología
Keywords: Atorvastatin
Inflammation Markers
C-Reactive Protein
Phospholipase A2
Issue Date: 2011
Publisher: 0168-8227
Journal: Diabetes Research and Clinical Practice 
Abstract: A randomized, crossover study compared the effects of atorvastatin, gemfibrozil and their combination on inflammatory markers in type 2 diabetes. C-reactive protein (CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2), secretory phospholipase A2 (sPLA2), interleukin 8 (IL8), monocyte chemotactic protein 1 (MCP1) and tumor necrosis factor alpha (TNF alpha) were measured. Both lipid-lowering drugs had positive, complementary and additive effects on inflammatory markers, which were closely related to baseline inflammatory status.
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2011.03.009
Source: Diabetes Research and Clinical Practice [ISSN 0168-8227], v. 93 (1), p. E25-E28, (Julio 2011)
Appears in Collections:Artículos
Show full item record

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.